S. Wittebol

1.1k total citations
16 papers, 581 citations indexed

About

S. Wittebol is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, S. Wittebol has authored 16 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in S. Wittebol's work include Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). S. Wittebol is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer therapeutics and mechanisms (3 papers). S. Wittebol collaborates with scholars based in Netherlands, Belgium and United States. S. Wittebol's co-authors include Pieter Sonneveld, Bob Löwenberg, Joost M. Bakker, HM Lokhorst, Tuna Mutis, Michael S. van der Veer, Michel de Weers, Berris van Kessel, Paul W.H.I. Parren and M. Schoester and has published in prestigious journals such as Blood, Clinical Infectious Diseases and British Journal of Haematology.

In The Last Decade

S. Wittebol

16 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Wittebol Netherlands 10 387 272 198 114 107 16 581
Eva Hoke United States 14 390 1.0× 231 0.8× 183 0.9× 157 1.4× 239 2.2× 22 662
Susana Vives Spain 10 533 1.4× 209 0.8× 272 1.4× 152 1.3× 231 2.2× 37 791
Susan R. Wiersma United States 13 260 0.7× 78 0.3× 137 0.7× 75 0.7× 175 1.6× 16 517
Nikhil Patkar India 15 295 0.8× 164 0.6× 115 0.6× 130 1.1× 289 2.7× 88 627
SN Wolff United States 10 421 1.1× 397 1.5× 133 0.7× 229 2.0× 145 1.4× 13 822
Giuseppe Console Italy 15 475 1.2× 302 1.1× 130 0.7× 87 0.8× 60 0.6× 51 633
P. Y. Leprise France 7 143 0.4× 358 1.3× 172 0.9× 121 1.1× 173 1.6× 8 575
Rosella Matera Italy 13 253 0.7× 147 0.5× 122 0.6× 184 1.6× 70 0.7× 28 472
Aïssata Tolo Ivory Coast 7 261 0.7× 113 0.4× 82 0.4× 131 1.1× 143 1.3× 17 423
R. Schlenk Germany 10 473 1.2× 96 0.4× 183 0.9× 139 1.2× 180 1.7× 20 629

Countries citing papers authored by S. Wittebol

Since Specialization
Citations

This map shows the geographic impact of S. Wittebol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wittebol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wittebol more than expected).

Fields of papers citing papers by S. Wittebol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Wittebol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wittebol. The network helps show where S. Wittebol may publish in the future.

Co-authorship network of co-authors of S. Wittebol

This figure shows the co-authorship network connecting the top 25 collaborators of S. Wittebol. A scholar is included among the top collaborators of S. Wittebol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Wittebol. S. Wittebol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Schaafsma, Martyn Ronald, Peter Joosten, E.F.M. Posthuma, et al.. (2015). Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study. Quality of Life Research. 24(12). 2895–2906. 36 indexed citations
2.
Schaafsma, M. Ronald, Okke de Weerdt, Peter Joosten, et al.. (2013). Real-world costs of chronic lymphocytic leukaemia in the Netherlands. Leukemia Research. 38(1). 84–90. 8 indexed citations
3.
Kater, Arnon P., S. Wittebol, Martine E.D. Chamuleau, Michel van Gelder, & Marinus H. J. van Oers. (2011). Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.. Research Publications (Maastricht University). 69(10). 422–9. 4 indexed citations
4.
Rijneveld, Anita W., Bronno van der Holt, Simon Daenen, et al.. (2011). Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. Leukemia. 25(11). 1697–1703. 55 indexed citations
5.
Veer, Michael S. van der, Michel de Weers, Berris van Kessel, et al.. (2010). Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab. Haematologica. 96(2). 284–290. 168 indexed citations
6.
Deenik, Wendy, Jeroen J. W. M. Janssen, Bronno van der Holt, et al.. (2009). Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia. Haematologica. 95(6). 914–921. 19 indexed citations
7.
8.
Lange, Dylan W. de, Rob Fijnheer, & S. Wittebol. (2003). [Acquired von Willebrand syndrome].. PubMed. 147(37). 1808–11. 2 indexed citations
9.
Wittebol, S., et al.. (2001). [Immunologic phenomena as the first sign of myelodysplastic syndrome].. PubMed. 145(32). 1529–33. 2 indexed citations
10.
Segeren, Christine M., Pieter Sonneveld, Bronno van der Holt, et al.. (1999). Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma. British Journal of Haematology. 105(1). 127–130. 76 indexed citations
11.
12.
Galama, J M, Nicole de Leeuw, S. Wittebol, H. M. Peters, & Willem J. G. Melchers. (1996). Prolonged Enteroviral Infection in a Patient Who Developed Pericarditis and Heart Failure After Bone Marrow Transplantation. Clinical Infectious Diseases. 22(6). 1004–1008. 19 indexed citations
13.
Raymakers, Reinier, et al.. (1995). Residual normal, highly proliferative progenitors can be isolated from the CD34+/33- fraction of AML with a more differentiated phenotype (CD33+).. PubMed. 9(3). 450–7. 19 indexed citations
14.
Locht, L. T. F. Van De, Toon F.C.M. Smetsers, S. Wittebol, Reinier Raymakers, & E. J. B. M. Mensink. (1994). Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia.. PubMed. 8(10). 1780–4. 18 indexed citations
15.
Leeuw, K. De, M. Schoester, S. Wittebol, et al.. (1993). Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood. 82(10). 3157–3162. 6 indexed citations
16.
Leeuw, K. De, M. Schoester, S. Wittebol, et al.. (1993). Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells. Blood. 82(10). 3157–3162. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Hoke Breakdown of academic impact, for papers by Susana Vives Breakdown of academic impact, for papers by Susan R. Wiersma Breakdown of academic impact, for papers by Nikhil Patkar Breakdown of academic impact, for papers by SN Wolff Breakdown of academic impact, for papers by Giuseppe Console Breakdown of academic impact, for papers by P. Y. Leprise Breakdown of academic impact, for papers by Rosella Matera Breakdown of academic impact, for papers by Aïssata Tolo Breakdown of academic impact, for papers by R. Schlenk
Rankless by CCL
2026